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ABSTRACT
Laura Brooke Carter: Parent Satisfaction with Diabetes Technology in Children with
Type 1 Diabetes Mellitus
(Under the direction of Dr. Donna West-Strum)
Purpose: To increase glucose control, advanced technologies are being integrated into
diabetes self-management in children with Type 1 Diabetes Mellitus (T1DM). Two
technologies being adopted is Continuous Subcutaneous Insulin Infusion (CSII), more
commonly known as insulin pumps (pumps) and Continuous Glucose Monitoring
(CGM). The purpose of the study was to better understand the experiences of parents
whose T1DM child is using insulin pumps and CGM devices in diabetes selfmanagement.
Methods: This study was approved by the University of Mississippi IRB. A crosssectional study was conducted using a sample of parents in the Mid-South region of the
U.S. The local chapters of JDRF and Camp Hopewell sent an e-mail inviting parents to
participate with a link to the electronic survey. A follow-up e-mail reminder was sent a
week after the initial e-mail was sent. SPSS 20.0 (Chicago, IL) was used to calculate
frequencies and descriptive statistics.
Results: 98 parents of children with TIDM responded to the survey, with only 47
families indicating their child was currently using an insulin pump and/or CGM device.
Participants described the relationship they experience with their physician. Then,
participants reported which members of their health care team helped them integrate
technology into their child’s diabetes self-management and the support they receive
pertaining to integrating technology into the child’s diabetes self-management.
Respondents indicated their sources of information about integrating advanced diabetes
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technology into their child’s diabetes management. Participants also ranked the benefits
and barriers associated with insulin pump and CGM device use.
Conclusion: Families with better patient-physician relationship quality and with more
perceived support from their diabetes health care team were more satisfied with insulin
pump use. However, few children in this geographic area have integrated CGM into
diabetes self-management. There are psychosocial issues to consider when integrating
insulin pumps and CGM into diabetes self-management. Some healthcare professionals,
including pharmacists, may be underutilized. As more patients attempt to adopt advanced
technologies, it will be important for pharmacists to be trained to help patients use their
insulin pump and CGM devices.
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BACKGROUND
Juvenile diabetes (Type 1 diabetes mellitus (T1DM)) is an autoimmune disease causing
insulin production to stop within the beta cells of the pancreas. Insulin is a hormone
produced by the beta cells of the pancreas and functions to promote anabolism by
regulating blood glucose concentrations (Fox, 2011). Without insulin, excess glucose
remains in the blood, leading to serious health problems. The Juvenile Diabetes Research
Foundation (JDRF) estimates that as many as three million Americans have T1DM. It is
also estimated that more than 15,000 children and 15,000 adults are diagnosed with
T1DM each year in the United States (JDRF, 2013).

In Type 1 diabetes management, patients must balance diet, exercise, insulin
management, and blood glucose level monitoring in order to maintain appropriate
glucose levels within the body. Too little glucose in the blood (hypoglycemia) or too
much glucose in the blood (hyperglycemia) results in detrimental health effects for
patients (Fox, 2011). The Mayo Clinic notes that hypoglycemic effects occur quickly and
can result in anxiety, shakiness, sweating as well as confusion, blurred vision, seizures,
and loss of consciousness. The effects of too much glucose in the blood (hyperglycemia),
on the other hand, often occur later in life. Early symptoms include frequent urination,
increased thirst, blurred vision, fatigue and headache. Later signs include damage to
extremities, neuropathy, retinopathy, heart problems, and brain damage (The Mayo
Clinic, 2013). Therefore, monitoring glucose levels and appropriate use of diabetes
medication is essential to the life and health of diabetes patients. The Diabetes Control
and Complications Trial (DLCT) study in TIDM shows that “intensive” glycemic control
can lower the risk of long-term diabetes complications (DLCT Research Group, 1993).
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Measuring glucose levels can be achieved using many different modalities. The Oral
Glucose Tolerance Test (OGTT) evaluates the efficiency of the body to metabolize
glucose and is considered to be the “gold standard" in the diagnosis of diabetes. This test
is accepted as a diagnostic modality by the American Diabetes Association, The World
Health Organization, The International Diabetes Federation, and many other
organizations (Sacks, 2011). Another essential test for patients with diabetes is the
measurement of HbA1C. The HbA1C test analyzes the non-enzymatic attachment of
glucose to hemoglobin. Because the life span of a red blood cell is approximately one
hundred and twenty days the HbA1C test allows health care professionals to measure the
average blood glucose concentration during the preceding 8-12 weeks. Good long-term
glycemic control results in lower HbA1C values and fewer complications for patients
(Sacks, 2011).

The HbA1C goals for children, according to the American Diabetes Association, are <
8.5% for patients younger than 6 years old, < 8.0% for patients between ages 6 to 13, and
< 7.5% for patients between the ages of 13 to 20 years old. Despite the importance of
tight glycemic control these targets were only met by 64, 43, and 21% of patients,
respectively (Wood et al., 2013). Juvenile patients with Type 1 diabetes are treated with
intensive insulin regimens; yet many patients are unable to achieve and maintain
recommended HbA1c targets (JDRF-CGM, 2010). It is often difficult for patients to
determine how much insulin is needed, to monitor blood glucose continuously using a
blood glucose meter, and to eat appropriately at all times.
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Newer Technologies in Diabetes Self-Management
In order to increase glucose control, newer, advanced technologies are being integrated
into diabetes self-management. Continuous subcutaneous insulin infusion (CSII), more
commonly known as insulin pumps (pumps), has been available for use since the 1980s.
Insulin pumps are a diabetic technology that replaces insulin shots by delivering insulin
in three unique ways. Pumps deliver insulin through small tubing called a cannula into a
catheter that is inserted into the skin. Insulin is then absorbed from the subcutaneous
tissue. Pumps have a basal rate that delivers small increments of rapid/short-acting
insulin at programmed rates throughout the day to match the patient’s baseline insulin
requirements. The basal rate replaces long-acting insulin injections and accounts for
approximately 50% percent of a person’s total daily insulin needs. Next, pumps deliver
boluses that provide additional insulin boosts to account for ingested carbohydrates or
hyperglycemia (Boyd & Boyd, 2008). Finally, pumps can deliver corrections, which
adjust pre-meal blood glucose values (Klobassa & Moreland, 2013).

Studies have shown that insulin pumps improve diabetes self-management. Boyd and
Boyd (2008) noted that the utilization of insulin pump therapy allowed patients to
achieve equivalent or better glycemic control while using less insulin. Additionally,
patients using insulin pump therapy experienced fewer and less severe hypoglycemic
events (Boyd & Boyd, 2008). Mednick and colleagues (2004) conducted a survey where
22 children with T1DM and their parents were asked to complete a satisfaction with
insulin pump therapy questionnaire. The results indicated that both parents and the
children were satisfied with the insulin pump use. They agreed that insulin pump usage
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increased the flexibility related to eating, sleeping, and food variety (Mednick, Cogen, &
Streisand, 2004).

Although insulin pumps have shown to improve blood glucose control, they are not used
widely. It is believed that only 22% of youths with TIDM have used insulin pump
therapy. The direct cost of insulin pump therapy is estimated to be twice the cost of
traditional multiple daily injections (MDI). Insulin pump therapy use is associated with
high household incomes, having private healthcare insurance, a higher level of parental
education as well as being Caucasian (Shukman, Palmert, & Daneman, 2012). Estimates
of discontinuation in children and adults range from 0-64% (Gonder-Frederick, Shepard,
& Peterson, 2011). Some reasons for discontinuation include skin discomfort, infection
at infusion site, anxiety about technology, body image concerns, cost/insurance issues,
technical difficulties with pump, inconvenience, and dislike or difficulty with needle
insertion (Gonder-Frederick et al., 2011). Few studies have examined child and parent
experiences with insulin pumps in the real world.

A newer diabetic technology designed to improve glucose control is Continuous Glucose
Monitoring (CGM). CGM is used to continuously monitor blood glucose levels by
providing frequent, real-time feedback about glucose levels and retrospective 24 –hour
glucose profiles (JDRF, 2010). A CGM device is a sensor that records blood glucose
levels throughout the day and night, providing up to 288 blood sugar measurements every
twenty-four hours. A CGM device has a tiny glucose-sensing instrument under the skin
and the rest of a CGM device is held in place by adhesive material on the top of the skin.
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Additionally, the CGM device has alarms to alert patients to hyper- or hypoglycemia
(Bloomgarden, Freeman, & Derobertis, 2008). By alerting juvenile patients to changes in
blood glucose, the CGM device seeks to provide better control of blood sugar for
patients. Remote glucose monitors can be used with CGM. Remote glucose monitors
allow parents to monitor blood glucose throughout the night. CGM technology can
dramatically improve day-to-day management of diabetes and promises to be a major
advancement in diabetes care (JDRF-CGM, 2010). It is important to note that a CGM
device still requires self-monitoring of blood glucose (SMBG) for accurate calibration of
CGM.

Real-time use of CGM allows parents to respond promptly to hyperglycemia or
hypoglycemia and provide more stable glucose levels (JDRF Continuous Glucose
Monitoring Study Group, 2010). Recent studies have confirmed the clinical benefits of
using CGM including making day-to day decisions based on 1-minute glucose readings,
threshold and projected glucose alarms, and glucose trend arrows that enable the
observation of the rate and direction of glucose change (Bloomgarden et al., 2008).
However, the JDRF Continuous Glucose Monitoring Study Group stated, “While these
studies suggest promise for CGM, questions remain regarding the potential effects of its
incorporation into diabetes management on psychosocial and patient-reported outcomes.
The extent to which CGM exerts positive or negative psychosocial effects could
influence patients’ frequency and persistence of CGM use” (JDRF Continuous Glucose
Monitoring Study Group, 2010).
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CGM is generally well-tolerated in children with T1DM for short intervals; however,
their use declines over extended time periods. Tansey and colleagues found that more
frequent monitoring was associated with higher satisfaction for parents of youths enrolled
in the JDRF CGM trials. Parents like having glucose trend data and the opportunity to
detect hypoglycemia and correct out-of-range glucose levels. However, there are
common barriers to continued use, including insertion pain, system alarms, and body
issues (Tansey et al., 2011). The Journal of Health Technology Assessment notes that
infection at injection site, difficulty with needle insertion, insurance difficulties, and the
technical aspects of CGM use often effect integration of CGM into diabetic care
(Cummins et al., 2010). Two barriers to using CGM are abundance of data increases
anxiety and lack of information about how to use technology (Godnder-Frederick et al.,
2011).

As use of CGM is associated with improved glucose control, clinicians will need to find
ways to help patients overcome barriers and set realistic expectations to promote its use
in children with T1DM. New strategies to increase acceptance and long-term use are
needed for youth with T1DM. Gonder-Frederick and colleagues suggested more provider
support, more education, and more monitoring will be necessary to improve the adoption
and utilization of CGM (Gonder-Frederick et al., 2011). Currently, little is known about
the psychosocial aspects of integrating CGM into diabetes self-management in children
with T1DM in the real-world (JDRF Continuous Glucose Monitoring Study Group,
2010).
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Gonder-Frederick and colleagues (2011) reviewed studies that have investigated adoption
of insulin pumps or CGM systems and concluded that more work is needed to understand
how to help patients adopt and utilize advanced technologies in diabetes selfmanagement. More studies are needed to investigate the experiences of parents and
children who are currently using insulin pumps and CGM in today’s health care system.
Clinical trials have shown the clinical benefits of using these newer, advanced
technologies and have provided insight into the use of these technologies. Yet, there is a
need to further understand the experiences of parents and children with T1DM in
integrating these technologies into their diabetes self-management routines in the realworld.

Provider Support with Advanced Diabetes Technology
The importance of glycemic control cannot be stressed enough for juvenile T1DM
patients. “Unlike many other chronic conditions, complications associated with diabetes
are preventable. Patient engagement is absolutely necessary to change negative behaviors
and to facilitate the self-confidence necessary for effective self-management.” (Gruber,
2010). The patient-physician relationship is one key variable influencing patient
engagement and diabetes self-management. Heisler et al. (2002) noted that to facilitate
patient self-management for chronic diseases, a shift to more collaborative patientprovider interaction styles with joint definitions of problems, treatment goals, and
management strategies is needed. Additionally, enhancing patient-provider
communication and shared decision making have been shown to result in greater patient
satisfaction, adherence to treatment plans, and improved health outcomes (Heisler et al.,
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2002). A positive therapeutic alliance can improve glycemic control in T1DM patients
(Attale, 2010). Similarly, Heisler et al. (2002) found that provider communication
effectiveness influences diabetes self-management. Furthermore, they found that
increasing the amount of information about diabetes and treatment improves patient
understanding and improves diabetes self-management.

The ability to access and utilize information about diabetes care can improve patient
understanding and self-management. This supports the importance of including
information about newer, advanced technologies in diabetes self-management programs.
Information about newer technologies will be essential to integrating their use into
diabetes self-management. It is likely that relationships with health care providers and
availability of information can facilitate the integration of technology into diabetes selfmanagement in juvenile patients with T1DM. Additional research is needed to better
understand how health care providers and accessible information can influence
technology integration into diabetes self-management.

Insulin use and tight glycemic control are difficult for most juvenile T1DM patients.
Although the incorporation of newer, advanced technologies into diabetes care has
increased the patient’s ability to control their blood glucose, adoption of technology is not
widespread. Further study is needed to understand how to improve the integration of
technology into diabetes self-management, especially in children and adolescents.
Furthermore, health care provider relationships and the availability of information about
newer technologies are likely to play a role in the adoption and integration of technology
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into diabetes self-management. Throughout this study, we sought to better understand
the experiences of using these newer, advanced technologies, specifically insulin pumps,
of parents with children with T1DM.

PURPOSE
The purpose of this study is to better understand the experiences of parents whose T1DM
child is using advanced technologies (i.e., insulin pumps and/or CGM) in diabetes selfmanagement. The specific objectives were:
1. To describe perceived health care provider support for integrating advanced
technologies into diabetes self-management in children with T1DM
2. To identify information sources for integrating advanced technologies into
diabetes self-management in children with T1DM
3. To describe satisfaction (benefits and barriers) of parents of children with T1DM
using insulin pumps and CGM
4. To explore the relationship between perceived health care provider support and
satisfaction with insulin pumps
H1: The better the patient-physician relationship quality, the more satisfied the
parent of a child with T1DM will be with the insulin pump
H2: The higher the perceived diabetes health care team support, the more
satisfied the parent of a child with T1DM will be with the insulin pump

The results of this study will assist in determining how health care providers and others
can improve the integration of advanced technologies into diabetes self-management in
children with T1DM. The results will inform health care providers on how to improve
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diabetes self-management training programs and other resources necessary to facilitate
the integration of advanced technologies into everyday diabetes self-management.
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METHODOLOGY
Data Collection:
The study was approved by the University of Mississippi IRB. The study used a crosssectional survey design. The survey was administered online and required about fifteen
minutes to complete. Each potential participant was sent an e-mail invite with a follow-up
reminder one week later.

Sample:
Mid-South parents who have a T1DM child 18 years old or younger using an insulin
pump and/or CGM were invited to participate in the study. The Northwestern Arkansas,
West Tennessee, and Mississippi chapters of the Juvenile Diabetes Research Foundation
(JDRF) agreed to send an email invitation that contained a link to the survey to their
members. A follow-up e-mail was sent one week later. The Nashville JDRF chapter
placed a link on their Facebook page. Camp Hopewell in Oxford, MS which offers a
summer camp specifically for children with TIDM, also sent the survey to parents in their
database who have children with T1DM. The invite e-mail provided information about
the purpose of the study and that the study was voluntary and anonymous. To identify
parents who had a T1DM child under the age of 18 and who were using advanced
technology, several screening questions were included in the survey.

Survey Instrument:
The electronic survey was developed using Qualtrics®. It quantitatively measured the
variables, necessary to address the study objectives. The survey is attached in Appendix
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A. Screening questions asked the potential participant if he/she had a child with T1DM
who is currently 18 years old or younger. If the participant answered yes, he/she was
asked if the child was currently using an insulin pump or continuous glucose monitor
(CGM). If he/she answered no, he/she was asked to identify reasons for not using
advanced technologies. If he/she answered yes, he/she qualified to the complete survey.

Survey Questions:
The first part of the survey included demographic and health status variables about the
parent respondent or child with T1DM. A technology anxiety variable was also included
in the survey to use as a covariate to account for differences in people’s general
perceptions of technology. This variable is measured using six items adapted from a
technology anxiety scale used by Meuter, Ostrom, Bitner, & Roundtree (2003).

The next part of the survey measured perceived health care provider support using two
measures.


The patient-physician relationship quality was measured using a scale adapted
from Worley, 2006. Parents indicated on a 7-point linear numeric scale
whether they strongly disagree or strongly agree with eight items pertaining to
the quality of the relationship with the primary health care provider for their
child’s diabetes care.



Perceived diabetes health care team support for integrating technology into
diabetes self-management was measured. This measure was adapted from the
Health Care Climate Questionnaire, which is a 10-item instrument that
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measures provider support (i.e., the extent to which health care providers
acknowledge and support patients’ self-management of chronic illness). This
measure has been used in patients with mental health disorders and had a
Cronbach’s alpha of 0.95 (Perron, Zeber, Kilbourne, & Bauer, 2009). The
measure was adapted to include technology integration into the items.
Respondents were also asked to identify from a list of potential providers who
they considered to be part of their child’s diabetes health care team who help
them integrate technology into diabetes self-management.

The third part of the survey included questions about sources of information about
diabetes technology. This information was used to measure which sources parents rely
on for information about how to integrate advanced technologies into diabetes selfmanagement. Respondents were also asked about their perceptions of information
quality. The parent was asked to indicate the strength of various information attributes
using a semantic differential scale.

The fourth part of the survey included questions about the parent’s and child’s
experiences with insulin pumps (e.g., number of years using pump, how many pumps
used). Insulin pump satisfaction was measured using the Insulin Pump Therapy
Satisfaction questionnaire. This questionnaire is a standardized measure of satisfaction
with insulin pump that includes four items related to satisfaction, preparedness, ease of
use, and ease of use relative to expectations and six additional items that assess key areas
of life change associated with using the pump. In a previous study, these 10 items had
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acceptable reliability with a Cronbach’s alpha of 0.69 (Mednick et al., 2004). To assess
the barriers to insulin pump use, a question with several barriers identified from the
literature was included whereby parents select the most common barriers to continued
use.

The final part of the survey addressed satisfaction with CGM devices. We adapted the
CGM Satisfaction Scale to use in this study. The CGM Satisfaction Scale was designed
to measure the impact of using CGM on diabetes management and family relationships
and on satisfaction with emotional, behavioral, and cognitive effects of CGM use.
(Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group,
2010). This scale included two subscales: a benefits of CGM subscale with 19 items
(Cronbach’s alpha =0.93) and a hassles of CGM subscale with 20 items (Cronbach’s
alpha=0.93). We selected 11 items from each subscale to include in our survey. Parents
indicated their agreement with each item using a 7-point linear numeric scale where 1 =
Strongly disagree and 7 = Strongly agree.

The survey was professionally examined for face validity by diabetes experts. Three
diabetes health care professionals were asked to critique and comment on the survey
questions and items. Face validity is important to ensure that the measure represents all
facets of the concept. Their comments were used to make revisions in the survey content.
Further, a pretest of the instrument was undertaken by administering it to three parents at
a diabetes clinic to determine the approximate time needed to complete the entire
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questionnaire, the wording, and item clarity. Based on the feedback from the pretest, the
instrument was revised before administering it to parents.

Analysis:
Once the survey was closed, data were transferred from Qualtrics® to SPSS 20.0
(Chicago, IL) for analysis. Data were reviewed for missing data and any survey missing
responses to more than 50% of the eligible items were deleted from the analysis file.
Frequencies and descriptive statistics were calculated. Correlation coefficients were
calculated to test the hypotheses at the 0.05 level of significance.
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RESULTS
In this pilot study, 98 parents responded to the survey. Of the 98 parent responses, 66
parents indicated that they did have a child eighteen years old or younger with TIDM.
From the 66 responses, 18 parents indicated that their child does not currently use an
insulin pump or CGM while 48 parents indicated that their child does use an insulin
pump or CGM. One parent of the 48 parent responses only provided demographic
information in the survey and was therefore excluded. Thus, the survey produced 47 final
responses from parents of children with TIDM who are currently utilizing an insulin
pump and/or CGM device. Table I below indicates these results.
Table I: Parents Reponses to Pilot Study

Information requested
Completed surveys

Survey
Responses
98

Do you have a child with Type 1 Diabetes who is currently 18
years old or younger?

Yes: 66
No: 32

Is your child currently using an insulin pump and/or a CGM to
manage his/her diabetes?

Yes: 48
No:18

Only provided demographic information

1

Total number of parent responses to the survey who have a
child eighteen years old or younger that is currently use an
insulin pump and/or CGM device.

47

The eighteen parents whose children do not use insulin pumps and/or CGM devices were
asked to select reason(s) for not using advanced diabetes technology. From the list of
reasons for not using advanced diabetes technology, the two most common reasons were
cost issues (33%) and the potential for interference with sports, playing outside, or other
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activities (22.2%). Other issues included pain or discomfort with infusion or insertion
site, body image concerns, and health care provider had not recommended.

Forty-seven participants had a child currently using an insulin pump and/or CGM and
participated in the survey. Forty-three of the 47 participants were white, 36.2% live in a
rural community, and 76.6% have a college degree or higher. Ninety-six percent have
private insurance. On the technology anxiety scale, the mean score on the six items was
3.96, indicating that a parent’s natural technology aptitude does not strongly affect their
desire to adopt and use diabetes technology.

Sixty-four percent of the respondents had a male child with diabetes. The mean child’s
age was 13.87 (range 6-18), and the mean age when diagnosed with T1DM was 8.09.
Sixty-two percent of respondents indicated that their child’s HbA1c at last visit was less
than 8.0%, and 23.4% indicated it was between 8-9%, and 14.9% indicated it was above
9%.

Objective 1: To describe perceived health care provider support for integrating
advanced technologies into diabetes self-management in children with T1DM

Patient-physician relationship quality was measured using eight items, where the
participant rated on a 7-point scale the level of agreement with each item. The results are
shown in Table II. The overall mean score for patient-physician relationship quality for
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the eight items was 6.28, indicating a positive relationship with the primary health care
provider in general.

Table II: Mean Item Scores for Patient-Physician Relationship Quality
Item
Mean Score*
My child's primary health care provider is trustworthy
6.62
I trust that my child's primary health care provider will
6.49
alert me of any problems with my child's diabetes
There are times when my child's primary health care
6.13
provider seems sincere
My child's primary health care provider always puts my
6.17
child's best interests first
I am satisfied with my child's primary health care
6.17
provider
I receive useful information about my child's diabetic
5.93
technology from my child's primary health care provider
I value the services that my child's primary health care
6.41
provider provides to my child and me
I am grateful for the individualized attention my child
6.29
receives from his/her primary health care provider
*7-point scale where 1 = strongly disagree and 7 = strongly agree

Participants were asked to indicate who they considered to be part of the child’s diabetes
health care team who help integrate diabetes technology into the child’s diabetes
management, as indicated in Table III. Participants reported that on average they had
3.83 members on their health care team that helped them integrate technology into their
child’s diabetes self-management. Parents were then asked about the support they receive
from the diabetes health care team pertaining to integrating technology into the child’s
diabetes self-management. Individual item scores for the nine items are provided in
Table IV. The scale demonstrated good internal consistency reliability (Cronbach’s alpha
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= 0.98). The overall mean score for the nine items was 5.97 (range = 1.78 to 7.00),
indicating support with room for improvement.
Table III: Members of Health Care Team Who Help Integrate Technology into
Child’s Diabetes Self-Management
Health Care Team Members
Frequency of Health Care Team
Member Utilization N (%)
Pediatric Endocrinologist/Endocrinologist
38 (80.9%)
Certified Diabetes Educator (CDE)
27 (57.4%)
Diabetes Technology Company
23 (48.9%)
Representative
Nurse/ Nurse Practitioner
19 (40.4%)
Pediatrician/Other Family Doctor
16 (34%)
Diabetic Supplier
11 (23.4%)
Pharmacist
11 (23.4%)
Dietician
9 (19.1%)
Board Certified – Advanced Diabetes Manager
4 (8.5%)
(BC-ADM)
Table IV: Mean Item Scores for Perceived Diabetes Health Care Team Support
Item
Mean Score*
I feel that my child’s diabetes health care team has
5.95
provided me choices and options with advanced diabetes
technology.
I feel understood by my child’s diabetes health care
6.14
team.
My child’s diabetes health care team conveys confidence
6.26
in my ability to make change with advanced diabetes
technology.
My child’s diabetes health care team encourages me to
5.93
ask questions about advanced diabetes technology.
My child’s diabetes health care team tries to understand
5.86
how I see things before suggesting a new way of doing
things with advanced diabetes technology.
My child’s diabetes health care team made me aware of
5.88
what to expect from using advanced diabetes technology.
My child’s diabetes health care team has provided
5.81
training on advanced diabetes technology.
My child’s diabetes health care team regularly reviews
6.00
my child’s progress while using advanced diabetes
technology.
My child’s diabetes health care team makes sure we stay
5.88
in regular contact.
19

*7-point scale where 1 = strongly disagree and 7 = strongly agree
Objective 2: To identify information sources for integrating advanced technologies
into diabetes self-management in children with T1DM
Respondents indicated where they received information about integrating advanced
diabetes technology into their child’s diabetes management. Interestingly, respondents
identified health care professionals as well as local diabetes advocacy groups, the
Internet, and family and friends as sources of information. Parents rated the quality of
information on a semantic differential scale from one to seven, where a higher number is
more positive, by indicating how relevant, consistent, beneficial, adequate, and useful the
information is. The respondents indicated the information quality was high, with a mean
score of 6.09 for the five items.

Table V: Sources of Information for Integrating Advanced Diabetes Technology
Information Sources
Pediatric Endocrinologist/Endocrinologist
Local Advocacy Group
Diabetes Technology Company
representative
Internet
Certified diabetes Educator (CDE)
Friends and Family
Nurse/ Nurse Practitioner
Diabetic Supplier
Pediatrician/Other Family Doctor
Dietician
Pharmacist
Board Certified – Advanced Diabetes
Manager (BC-ADM)
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Frequency N(%)
25(53.2%)
24 (51.1%)
22 (46.8%)
20 (42.6%)
15 (31.9%)
13 (27.7%)
11 (23.4%)
7 (14.9%)
4 (8.6%)
3 (6.4%)
3 (6.4%)
1 (2.1%)

Objective 3: To describe satisfaction (benefits and barriers) of parents of children with
T1DM using insulin pumps and CGM
42 respondents indicated that their child was using an insulin pump, at the time of the
survey, in their diabetes self-management. Of the 42 respondents, 62.8% had used their
current insulin pump for more than two years, and 18.6% had used three or more
different insulin pumps. The majority of respondents indicated that either the diabetes
technology company representative (41.9%) or a CDE (39.5%) initially trained them on
the use of the technology. Others indicated that a nurse, physician, or BC-ADM trained
them initially.

Four items were used to measure satisfaction with insulin pumps, preparedness for
transition to insulin pumps, ease of use of insulin pumps, and difficulty of insulin pumps
use compared to expectation. Participants responded to these four questions, where a
higher number indicated a more positive response. The results are provided in Table VI.
When the results were scaled from one to five, the average satisfaction sum was 3.83.
Parents also reported the benefits of insulin pump integration by indicating the changes in
the quality of your child’s/your life as a result of using the insulin pump. Parents rated the
benefits by indicating any changes in the quality of your child’s/your life as a result of
using an insulin pump from 1 = much worse to 5 = much better. These results are
provided in Table VII. All agreed to some extent that the insulin pump had improved
their child’s quality of life.
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Table VI: Satisfaction with Insulin Pump
Item
Satisfaction with insulin pump
Preparedness for transition to insulin pump
Ease of use of insulin pump
Difficulty of insulin pump compared to expectation

Mean Score
3.95
4.05
3.91
3.51

Table VII: Changes in Quality of Life as a Result of Insulin Pump
Benefits
Mean Benefits Score
Flexibility of Meal Schedule
4.60
Food Variety
4.49
Flexibility of Sleep Schedule
4.47
Knowledge of Diabetes
4.09
Level of your child’s responsibility
3.88
Worry related to diabetes
3.81
*5 point scale where 1=much worse, 2= worse, 3=about the same, 4=better, and 5=much
better

Study participants also reported the top four challenges they have experienced as a result
of integrating insulin pumps into their child’s diabetes care. The most common barriers
reported were infusion site rotation issues (57.4%), cost and insurance issues related to
insulin pump supplies (52.2%), infusion site is uncomfortable/painful (44%), fear of
device malfunction (40.4%), and body image concerns (29.8%). Other barriers
experienced by a few participants included school issues, interference with
extracurricular activities, operating the pump, and calculating carbohydrate meal content.
Participants did not indicate that there were barriers related to lack of health care provider
support or lack of information.

Only 13 of the participants indicated that their child was currently using a CGM. Thirtyeight percent had been using a CGM for two or more years, and sixty-nine percent were
initially trained to use the CGM by either a CDE or a diabetes technology company
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representative. Three of the 13 have used a remote monitor. As shown in Table VIII,
respondents indicated their level of agreement with each benefit item. The mean score
for all 11 benefit items was 4.90. Table IX shows the level of agreement with each
barrier item. The mean score for all 11 barrier items was 3.27.
Table VIII: Mean Item Scores for ‘Benefits’ Associated with Using a CGM
Item
Mean Score*
makes adjusting insulin easier
4.85
helps to keep low blood sugars from happening
4.77
has helped us learn how to treat low sugars better
3.85
shows patterns in blood sugars that we didn't see before
5.85
helps us prevent problems rather than fixing them after
5.31
they have happened
allows more freedom in daily life
5.08
makes it clearer how some everyday habits affect blood
5.54
sugar levels
makes it easier to complete other diabetes management
4.54
duties
has helped adjust pre-meal insulin doses
4.00
has made me worry less about my child having low blood
4.85
sugars
helps in adjusting doses of insulin needed through the
5.31
night
*7-point scale where 1 = strongly disagree and 7 = strongly agree

Table IX: Mean Item Scores for ‘Barriers’ Associated with Using a CGM
Item
Mean Score*
causes others to ask too many questions about diabetes
3.00
makes us think about diabetes too much
2.67
causes too many hassles in daily life
3.83
sometimes gives too much information to work with
2.18
is uncomfortable or painful
5.08
has been harder or more complicated than expected
3.50
makes it harder for my child to sleep
2.92
shows more “glitches” and “bugs” than it should
4.33
interferes a lot with sports, playing outside, etc.
3.00
alarms too often for no good reason
3.17
the feedback from device is not useful
2.00
*7-point scale where 1 = strongly disagree and 7 = strongly agree
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Objective 4: To explore the relationship between health care provider support and
satisfaction with insulin pumps
H1: The better the patient-physician relationship quality, the more satisfied the
parent of a child with T1DM will be with the insulin pump
H2: The higher the perceived diabetes health care team support, the more
satisfied the parent of a child with T1DM will be with the insulin pump

The third objective was to explore the relationship between health care provider support
and satisfaction with insulin pumps. The overall mean score for the 8 items related to
patient-physician relationship quality was used to measure relationship quality, and the
one item pertaining to satisfaction with insulin pump was used as the insulin pump
satisfaction measure. To examine if the patient-physician relationship quality was related
to satisfaction with insulin pump, a correlation coefficient was calculated. Table X
presents the correlation coefficient between the two variables. The results indicated that
these two variables are significantly correlated. The hypothesis (H1) is supported.
Therefore, the better the patient-physician relationship quality, the more satisfied the
parent of a child with T1DM will be with the insulin pump.
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Table X: Correlation between Patient-Physician Relationship Quality and
Insulin Pump Satisfaction
Satisfaction with
Relationship Quality
insulin Pump
Satisfaction with insulin
1.0
.344
pump
Pearson correlation
Sig. (2-tailed)
0.030
N
43
40
Relationship quality
.344
1
Pearson correlation
Sig. (2-tailed)
0.030
N
40
43

Table XI presents the correlation coefficient between the perceived diabetes health care
team support and satisfaction with insulin pump use. The overall mean rating for the
perceived diabetes health care team support scale was used to measure perceived support,
and the one item pertaining to satisfaction with insulin pump was used as the insulin
pump satisfaction measure. The results indicated that these two variables are
significantly correlated. Hypothesis 2 was supported. Therefore, the higher the
perceived diabetes health care team support, the more satisfied the parent of a child with
TIDM is with the insulin pump.
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Table XI: Correlation between Perceived Diabetes Health Care Team Support
and Insulin Pump Satisfaction
Satisfaction with
Perceived Diabetes
Insulin Pump
Health Care Team
Support
Satisfaction with insulin
1
0.341
pump
Pearson correlation
Sig. (2-tailed)
0.027
N
43
42
Perceived Diabetes
0.341
1
Health Care Team
Support
Pearson correlation
Sig. (2-tailed)
0.027
N
42
43
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DISCUSSION
Diabetes is a multi-faceted disease. For parents with a child with diabetes,
health care provider support is essential in adopting, utilizing, and integrating new
diabetes technology. The goal of diabetes technology integration is to improve a child’s
healthcare outcomes and give the parents more control of their child’s diabetes
management. Our project was conducted through an Internet survey in which 42 parents
indicated that they currently an insulin pump to manage their child’s diabetes and 13
utilize a CGM device. The parents that participated in the survey had children who had
adopted and integrated advanced technology into their child’s diabetes self-management.
Also, the majority of parents who participated in the survey had private health insurance,
lived in an urban area, and were financially stable. This is consistent with the literature.
The average age of the child with diabetes was about 14 years old.
As the survey data were analyzed, it appeared that a parent’s inherent technology
aptitude does not affect their adoption of technology. Parents without superior technology
skills were able to adopt and integrate technology. Although diabetic technology can be
complex, it is accessible to families with both proficient and limited technology skills.
In order to attempt to understand a parent’s experience with technology, it is
essential to understand how health care providers can support the integration of advanced
technology into diabetes self-management. The relationship between physicians and a
patient and their family is key in diabetes care. Most of the parents surveyed used an
endocrinologist or a pediatric endocrinologist as their primary diabetes healthcare
provider. It was found that a better relationship with the physician resulted in parents
who were more satisfied with TIDM technology. Survey participants identified that they
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felt their relationship with their child’s primary health care provider was generally a
positive relationship. As seen in Table II, parents reported their child’s primary health
care provider was trustworthy, sincere, and put the needs of their child first.
Due to the complexities of diabetes management, a health care team is essential to
achieving diabetes goals. Survey participants had a variety of different individuals on
their health care team in addition to a primary health care provider who helped them
integrate advanced technologies into their self-management. Specifically, the certified
diabetes educator and the technology company representative play a pivotal role in
training patients/parents about the newer technology. Some health care professionals,
including pharmacists or dieticians, may be underutilized with respect to integrating
technology into diabetes self-management. As more patients attempt to adopt advanced
technologies, it will be important for the entire diabetes health care team to support the
adoption and integration of these technologies. Thus, more insulin pump and CGM
training for all professionals providing diabetes care may be needed.
The participants appeared to perceive support for integrating technology;
however, there is room for improvement. For example, parents rated the items related to
technology training, awareness of what to expect from technology, and encourages me to
ask questions about technology lower than some of the other items. Other results from
the survey indicated that even these adopters of technology still perceive barriers to using
the technology and dealing with some of the psychosocial issues resulting from the use of
technology. Again, it is suggested that further training may be needed to ensure diabetes
health care providers are prepared to facilitate the adoption and utilization of insulin
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pumps and CGM. This adoption has clinical, psychosocial, and economic implications
that must be consider by the diabetes health care team.
The results emphasize the need for health care professionals to be trained and
confident with diabetic technology and patient care. It may be important that every
member of a patient’s diabetes health care team be knowledgeable and helpful if asked
about integrating technology or technology-related challenges. Moreover, these results
may also indicate that patients may not be utilizing the resources provided by these health
care professionals. It is essential that health care professionals are not only educated
about diabetes technology but also make their abilities accessible to patients when and if
questions and concerns arise. If health care professionals are able to receive training and
feel comfortable assisting patients with technology related problems, it is possible to
improve the patients’ perceived provider support. Improving perceived support is likely
to improve the parent’s satisfaction with the technology.
Many benefits and barriers to utilizing diabetes technology exist. The benefits to
using insulin pumps related to flexibility of meal schedule and sleep schedule, allowing
the child/parent to have an improved quality of life. The parents did not seem
completely satisfied with the use of the insulin pump, although they have adopted its use.
Parents indicated that it was not easy to use and that it was more difficult to use
compared to what was expected. When provided with a list of sixteen common barriers
to using insulin pumps, three top barriers to technology emerged including problems with
infusion site rotations, cost and insurance issues related to insulin pump supplies, and the
fear of device malfunction. These top barriers identified with the insulin pump related to
how the device functions as opposed to how the technology impacts the daily life of the

29

child. This finding may indicate the need for continued improvement of the technology
as well as better ways to train and educate parents about the technology. Health care
providers will also need to be mindful of the cost burden associated with advanced
technologies.
Furthermore, the results show that incorporation of diabetes technology did not
alleviate worry related to diabetes, body image concerns, or the social aspect of device
usage. Although diabetes technology aids in diabetes self-management, more support is
necessary to combat the psychosocial issues related to technology integration. By
addressing some of the psychosocial aspects of technology integration, it may possible to
increase satisfaction and adoption of technology in juvenile diabetes management.
These results suggest that parents and children need continued support and
training to integrate technology into diabetes self-management. There are clinical,
economic, and psychosocial issues that need addressed. All diabetes providers need to
be prepared to facilitate the adoption and use of insulin pumps and CGM in T1DM
children. Furthermore, there will be an increased need for providers who are experts in
diabetes technology, such as the Certified Diabetes Technology Clinician. These
providers will be important in training patients on how to use the technology, troubleshooting when the technology malfunctions, and helping the patient adapt to the use of
technology.
This pilot study begins to shed light on the nature of diabetes technology adoption
and integration and the diabetes health care team support for technology integration. It
provides insight into the experiences of parents with T1DM children who are using
technology. These parents were not participating in other clinical trials so these results

30

reflect adopting technology in the real-world, particularly in the south. Further
investigation is needed to better understand the psychosocial aspects of technology
integration as well as methods to increase perceived support for adopting diabetes
technology. Research is needed to understand how various education and training
programs can improve the adoption of these technologies. One important part of this
research will be the nationwide technology survey planned by JDRF to better understand
technology usage in patients with diabetes and their caregivers.
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